Clinical Effects of Implantable Sacral Neuromodulation Combined with Floating Needle Reperfusion in the Treatment of Patients with Functional Defecation Disorders

Abstract

Objective: To investigate the clinical effect of implantable sacral neuromodulation combined with floating needle reperfusion in treating patients with functional defecation disorder. Methods: 40 eligible constipated patients with defecation disorder were screened according to the criteria of Rome IV for chronic constipation, and were divided into 20 cases each in the control group and the study group according to the random number table method. The control group was given oral lactulose combined with mosapride treatment, and the study group was given implantation of sacral nerve stimulation electrodes and floating needle reperfusion treatment. The clinical symptoms, visual analog scale (VAS) score, Wexner score for constipation, quality of life score, anorectal manometry, adverse reactions, and complications were observed in both groups. Results: After treatment, the median number of voluntary feces per week and the median number of days of voluntary feces per week in the study group were higher than those in the control group, and the median duration of defecation was lower than that in the control group (P < 0.05); the median VAS score of the study group was significantly higher than that of the control group (P < 0.05); the constipation Wexner score of the study group was significantly lower than that of the control group (P < 0.001); the quality of life scores of the study group were overall better than those of the control group (P < 0.05); the anal resting pressure, anal residual pressure, and rectal propulsion of the study group were significantly better than those of the control group (P < 0.05); liquefaction of the incision occurred in only one patient during treatment in the study group, which was healed after changing the medication and did not have any serious complications, and two patients in the control group had abdominal pain, and there was no significant difference between the two groups (P > 0.05). Conclusion: In the treatment of patients with functional defecation disorder, implantable sacral neuromodulation combined with floating needle reperfusion therapy can effectively improve the clinical symptoms and quality of life of patients.